Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Hair loss may indicate higher risk of heart disease.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Hair loss doesn't affect COVID-19 severity.

Severe COVID-19 often leads to hair loss in India.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Lower BDNF levels link to worse depression in alopecia areata patients.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The model accurately predicts hair loss severity in alopecia areata.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Many patients with Alopecia Areata in Korea experience anxiety, depression, and reduced quality of life, which are often unrelated to the severity of hair loss.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

miR-155-5p can help diagnose and track alopecia areata severity.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

Early hair loss may indicate prostate issues.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Baricitinib is effective and safe for treating severe alopecia areata.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Intralesional steroids improve Alopecia Areata, and trichoscopy effectively tracks this improvement.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Androgenetic alopecia in males is linked to significant psychological distress, highlighting the need for both mental and dermatological care.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.